Psoriasis Stocks List

Psoriasis Stocks Recent News

Date Stock Title
Jun 3 ABBV TJX, Sysco, Lululemon And A Healthcare Stock On CNBC's 'Final Trades'
Jun 3 ABBV AbbVie to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Jun 3 ARQT Arcutis to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Jun 3 BDRX Promising Phase 2 Results For Biodexa's eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have a 100% Lifetime Risk of Colorectal Cancer
Jun 3 BIIB Biogen and Delta Flight Products to Collaborate with Advocates and Patients to Inform the Future of Accessible Air Travel
Jun 3 ABBV ASCO 2024: AbbVie flexes early success of ADC pipeline in solid tumours
Jun 3 ABBV AbbVie (ABBV) Soars 3.2%: Is Further Upside Left in the Stock?
Jun 2 ABBV Emerging and Chinese pharmas playing greater role in oncology drug development
Jun 2 ROIV Roivant Sciences: Executing On Huge Buyback Program With More To Come
Jun 2 ABBV 3 No-Brainer Stocks to Buy in June
May 31 ABBV Gilead's (GILD) Urothelial Cancer Study Did Not Meet Its Primary Goal
May 31 BIIB Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
May 31 BIIB Repligen (RGEN) Down 10.9% Since Last Earnings Report: Can It Rebound?
May 31 INCY Sarepta Therapeutics (SRPT) Down 4.7% Since Last Earnings Report: Can It Rebound?
May 31 BIIB Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody
May 31 ARQT Are Medical Stocks Lagging Arcutis Biotherapeutics (ARQT) This Year?
May 31 BIIB How To Invest: Using Shorter-Term Moving Averages To Trade Stocks
May 31 ABBV AbbVie wins EU backing for Skyrizi in bowel disorder
May 31 BIIB European Commission approves Biogen’s QALSODY for ALS treatment
May 31 ABBV AbbVie Receives Positive CHMP Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Moderately to Severely Active Ulcerative Colitis
Psoriasis

Psoriasis is a long-lasting autoimmune disease characterized by patches of abnormal skin. These skin patches are typically red, dry, itchy, and scaly. On people with darker skin the patches may be purple in colour. Psoriasis varies in severity from small, localized patches to complete body coverage. Injury to the skin can trigger psoriatic skin changes at that spot, which is known as the Koebner phenomenon.There are five main types of psoriasis: plaque, guttate, inverse, pustular, and erythrodermic. Plaque psoriasis, also known as psoriasis vulgaris, makes up about 90 percent of cases. It typically presents as red patches with white scales on top. Areas of the body most commonly affected are the back of the forearms, shins, navel area, and scalp. Guttate psoriasis has drop-shaped lesions. Pustular psoriasis presents as small non-infectious pus-filled blisters. Inverse psoriasis forms red patches in skin folds. Erythrodermic psoriasis occurs when the rash becomes very widespread, and can develop from any of the other types. Fingernails and toenails are affected in most people with psoriasis at some point in time. This may include pits in the nails or changes in nail color.Psoriasis is generally thought to be a genetic disease that is triggered by environmental factors. In twin studies, identical twins are three times more likely to be affected compared to non-identical twins. This suggests that genetic factors predispose to psoriasis. Symptoms often worsen during winter and with certain medications, such as beta blockers or NSAIDs. Infections and psychological stress can also play a role. Psoriasis is not contagious. The underlying mechanism involves the immune system reacting to skin cells. Diagnosis is typically based on the signs and symptoms.There is no cure for psoriasis; however, various treatments can help control the symptoms. These treatments include steroid creams, vitamin D3 cream, ultraviolet light and immune system suppressing medications, such as methotrexate. About 75 percent of cases can be managed with creams alone. The disease affects two to four percent of the population. Men and women are affected with equal frequency. The disease may begin at any age, but typically starts in adulthood. Psoriasis is associated with an increased risk of psoriatic arthritis, lymphomas, cardiovascular disease, Crohn's disease and depression. Psoriatic arthritis affects up to 30 percent of individuals with psoriasis.

Browse All Tags